dr. J. (Jan) Westerink
Assistant Professor - medical
- Internal Medicine
Contact
Research Output (79)
The relation between healthy lifestyle changes and decrease in systemic inflammation in patients with stable cardiovascular disease
van ’t Klooster C. C., van der Graaf Y., Ridker P. M., Westerink J., Hjortnaes J., Sluijs I., Asselbergs F. W., Bots M. L., Kappelle L. J., Visseren F. L.J., mei 2020, In: Atherosclerosis. 301 , p. 37-43 7 p.
Apparent therapy-resistant hypertension as risk factor for the development of type 2 diabetes mellitus
Holtrop Joris, Spiering Wilko, Nathoe Hendrik M, De Borst Gert J, Kappelle Laurens J, De Valk Harold W, Visseren Frank L J, Westerink Jan, jan 2020, In: Journal of Hypertension. 38 , p. 45-51 7 p.
Intracranial Atherosclerotic Burden on 7T MRI Is Associated with Markers of Extracranial Atherosclerosis:The SMART-MR Study
Zwartbol M. H. T., Geerlings M. I., Ghaznawi R., Hendrikse J., van der Kolk A. G., Asselbergs F. W., Nathoe H. M., de Borst G. J., Bots M. L., Emmelot M. H., de Jong P. A., Leiner T., Lely A. T., van der Kaaij N. P., Kappelle L. J., Ruigrok Y. M., Verhaar M. C., Visseren F. L. J., Westerink J., 5 dec 2019, In: American Journal of Neuroradiology. 40 , p. 2016-2022 7 p.
Normal-range thyroid-stimulating hormone levels and cardiovascular events and mortality in type 2 diabetes
de Vries Tamar I., de Valk Harold W., van der Graaf Yolanda, de Borst Gert J., Cramer Maarten J.M., Jaap Kappelle L., Visseren Frank L.J., Westerink Jan 16 okt 2019, In: Diabetes Research and Clinical Practice. 157
The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes:A randomized, double-blind, placebo-controlled trial
Zwakenberg S. R., De Jong P. A., Bartstra J. W., Van Asperen R., Westerink J., De Valk H., Slart R. H.J.A., Luurtsema G., Wolterink J. M., De Borst G. J., Van Herwaarden J. A., Van De Ree M. A., Schurgers L. J., Van Der Schouw Y. T., Beulens J. W.J. 1 okt 2019, In: American Journal of Clinical Nutrition. 110 , p. 883-890 8 p.
Heterogeneity of treatment effects from an intensive lifestyle weight loss intervention on cardiovascular events in patients with type 2 diabetes:Data from the look AHEAD trial
De Vries Tamar I., Dorresteijn Jannick A.N., Van Der Graaf Yolanda, Visseren Frank L.J., Westerink Jan 1 okt 2019, In: Diabetes Care. 42 , p. 1988-1994 7 p.
Transcranial Doppler 24 Hours after Carotid Endarterectomy Accurately Identifies Patients Not at Risk of Cerebral Hyperperfusion Syndrome
Fassaert Leonie M.M., Immink Rogier V., van Vriesland Daniël J., de Vries Jean Paul P.M., Toorop Raechel J., Kappelle L. Jaap, Westerink Jan, Tromp Selma C., de Borst Gert J. 1 sep 2019, In: European Journal of Vascular and Endovascular Surgery. 58 , p. 320-327 8 p.
Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease:results from the COMPASS trial
de Vries Tamar I., Eikelboom John W., Bosch Jackie, Westerink Jan, Dorresteijn Jannick A.N., Alings Marco, Dyal Leanne, Berkowitz Scott D., van der Graaf Yolanda, Fox Keith A.A., Visseren Frank L.J. 1 sep 2019, In: European Heart Journal. 40 , p. 3771-3778a
The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease:a cohort study
Van't Klooster Cilie C, Ridker Paul M, Hjortnaes Jesper, van der Graaf Yolanda, Asselbergs Folkert W, Westerink Jan, Aerts Joachim G J V, Visseren Frank L J, 1 sep 2019, In: European Heart Journal. 40 , p. 3901-3909 9 p.
Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all-cause mortality: Findings from the SMART cohort
Sharif Shahnam, Groenwold Rolf H. H., van der Graaf Y., Berkelmans Gijs F. N., Cramer Maarten J., Visseren Frank L. J., Westerink Jan, van Petersen R., Dinther B. G. F., van der Graaf Y., Grobbee D. E., Rutten G. E. H. M., Visseren Frank L. J., de Borst G. J., Kappelle L. J., Leiner T., Nathoe H. M., aug 2019, In: Diabetes, Obesity & Metabolism. 21 , p. 1935-1943 9 p.